AstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day

Dow Jones2025-04-17

DJ AstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

The AstraZeneca PLC ADR $(AZN)$ shed 1.21% to $67.05 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 3.07% to 16,307.16 and Dow Jones Industrial Average falling 1.73% to 39,669.39.

This was the ADR's second consecutive day of losses.

AstraZeneca PLC ADR closed 23.52% short of its 52-week high of $87.68, which the company achieved on August 30th.

The ADR demonstrated a mixed performance when compared to some of its competitors Wednesday, as Eli Lilly & Co. $(LLY)$ fell 2.94% to $734.90, Biogen Inc. $(BIIB)$ fell 1.44% to $115.29, and Johnson & Johnson $(JNJ)$ rose 0.19% to $153.91.

Trading volume (3.6 M) remained 2.9 million below its 50-day average volume of 6.5 M.

Data source: Dow Jones Market Data, FactSet. Data compiled April 16, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

April 16, 2025 17:24 ET (21:24 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2528066342?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-17 05:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2528066342","market":"hk","top_or_hot":-1,"title":"AstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ AstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     The AstraZeneca PLC ADR <a href=\"https://laohu8.com/S/AZN\">$(AZN)$</a> shed 1.21% to $67.05 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 3.07% to 16,307.16 and Dow Jones Industrial Average  falling 1.73% to 39,669.39. \n</p>\n<p>\n     This was the ADR's second consecutive day of losses. \n</p>\n<p>\n     AstraZeneca PLC ADR closed 23.52% short of its 52-week high of $87.68, which the company achieved on August 30th. \n</p>\n<p>\n     The ADR demonstrated a mixed performance when compared to some of its competitors Wednesday, as Eli Lilly &amp; Co. <a href=\"https://laohu8.com/S/LLY\">$(LLY)$</a> fell 2.94% to $734.90, Biogen Inc. <a href=\"https://laohu8.com/S/BIIB\">$(BIIB)$</a> fell 1.44% to $115.29, and Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> rose 0.19% to $153.91. \n</p>\n<p>\n     Trading volume (3.6 M) remained 2.9 million below its 50-day average volume of 6.5 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled April 16, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 16, 2025 17:24 ET (21:24 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-04-17 05:24</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ AstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     The AstraZeneca PLC ADR <a href=\"https://laohu8.com/S/AZN\">$(AZN)$</a> shed 1.21% to $67.05 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 3.07% to 16,307.16 and Dow Jones Industrial Average  falling 1.73% to 39,669.39. \n</p>\n<p>\n     This was the ADR's second consecutive day of losses. \n</p>\n<p>\n     AstraZeneca PLC ADR closed 23.52% short of its 52-week high of $87.68, which the company achieved on August 30th. \n</p>\n<p>\n     The ADR demonstrated a mixed performance when compared to some of its competitors Wednesday, as Eli Lilly &amp; Co. <a href=\"https://laohu8.com/S/LLY\">$(LLY)$</a> fell 2.94% to $734.90, Biogen Inc. <a href=\"https://laohu8.com/S/BIIB\">$(BIIB)$</a> fell 1.44% to $115.29, and Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> rose 0.19% to $153.91. \n</p>\n<p>\n     Trading volume (3.6 M) remained 2.9 million below its 50-day average volume of 6.5 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled April 16, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 16, 2025 17:24 ET (21:24 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AZN","symbol_name":"阿斯利康","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2528066342","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2528066342","pubTimestamp":1744838640,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.The AstraZeneca PLC ADR  shed 1.21% to $67.05 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 3.07% to 16,307.16 and Dow Jones Industrial Average  falling 1.73% to 39,669.39.This was the ADR's second consecutive day of losses.AstraZeneca PLC ADR closed 23.52% short of its 52-week high of $87.68, which the company achieved on August 30th.The ADR demonstrated a mixed performance when compared to some of its competitors Wednesday, as Eli Lilly & Co.  fell 2.94% to $734.90, Biogen Inc.  fell 1.44% to $115.29, and Johnson & Johnson  rose 0.19% to $153.91.Trading volume  remained 2.9 million below its 50-day average volume of 6.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled April 16, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independen","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"AZN":"阿斯利康"},"translate_title":"尽管当天亏损，阿斯利康公司ADR的表现仍优于竞争对手","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AZN":1},"content_text":"DJ AstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     The AstraZeneca PLC ADR $(AZN)$ shed 1.21% to $67.05 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 3.07% to 16,307.16 and Dow Jones Industrial Average  falling 1.73% to 39,669.39. \n\n\n     This was the ADR's second consecutive day of losses. \n\n\n     AstraZeneca PLC ADR closed 23.52% short of its 52-week high of $87.68, which the company achieved on August 30th. \n\n\n     The ADR demonstrated a mixed performance when compared to some of its competitors Wednesday, as Eli Lilly & Co. $(LLY)$ fell 2.94% to $734.90, Biogen Inc. $(BIIB)$ fell 1.44% to $115.29, and Johnson & Johnson $(JNJ)$ rose 0.19% to $153.91. \n\n\n     Trading volume (3.6 M) remained 2.9 million below its 50-day average volume of 6.5 M. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled April 16, 2025. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 16, 2025 17:24 ET (21:24 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2528066342","isCrawlerRequest":true}